Literature DB >> 11832477

Folding of a de novo designed native-like four-helix bundle protein.

Alex Chapeaurouge1, Jonas S Johansson, Sérgio T Ferreira.   

Abstract

The folding of a model native-like dimeric four-helix bundle protein, (alpha(2))(2), was investigated using guanidine hydrochloride, hydrostatic pressure, and low temperature. Unfolding by guanidine hydrochloride followed by circular dichroism and intrinsic fluorescence spectroscopy revealed a highly cooperative transition between the native-like and unfolded states, with free energy of unfolding determined from CD data, DeltaG(unf) = 14.3 +/- 0.8 kcal/mol. However, CD and intrinsic fluorescence data were not superimposable, indicating the presence of an intermediate state during the folding transition. To stabilize the folding intermediate, we used hydrostatic pressure and low temperature. In both cases, dissociation of the dimeric native-like (alpha(2))(2) into folded monomers (alpha(2)) was observed. van't Hoff analysis of the low temperature experiments, assuming a two-state dimer 171-monomer transition, yielded a free energy of dissociation of (alpha(2))(2) of DeltaG(diss) = 11.4 +/- 0.4 kcal/mol, in good agreement with the free energy determined from pressure dissociation experiments (DeltaG(diss) = 10.5 +/- 0.1 kcal/mol). Binding of the hydrophobic fluorescent probe 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid (bis-ANS) to the pressure- and cold-dissociated states of (alpha(2))(2) indicated the existence of molten-globule monomers. In conclusion, we demonstrate that the folding pathway of (alpha(2))(2) can be described by a three-state transition including a monomeric molten globule-like state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832477     DOI: 10.1074/jbc.M105232200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Nm23-H1/NDP kinase folding intermediates and cancer: a hypothesis.

Authors:  Ioan Lascu
Journal:  J Bioenerg Biomembr       Date:  2006-09-01       Impact factor: 2.945

2.  Xylanase II from Trichoderma reesei QM 9414: conformational and catalytic stability to Chaotropes, Trifluoroethanol, and pH changes.

Authors:  G López; A Bañares-Hidalgo; P Estrada
Journal:  J Ind Microbiol Biotechnol       Date:  2010-09-14       Impact factor: 3.346

3.  Identification of acidic pH-dependent ligands of pentameric C-reactive protein.

Authors:  David J Hammond; Sanjay K Singh; James A Thompson; Bradley W Beeler; Antonio E Rusiñol; Michael K Pangburn; Lawrence A Potempa; Alok Agrawal
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

4.  Proposed Role for Internal Lens Pressure as an Initiator of Age-Related Lens Protein Aggregation Diseases.

Authors:  Alan N Glazier
Journal:  Clin Ophthalmol       Date:  2022-07-27

5.  Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis.

Authors:  Nahuel A Ramella; Omar J Rimoldi; Eduardo D Prieto; Guillermo R Schinella; Susana A Sanchez; María S Jaureguiberry; María E Vela; Sergio T Ferreira; M Alejandra Tricerri
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

6.  Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.

Authors:  Nahuel A Ramella; Guillermo R Schinella; Sergio T Ferreira; Eduardo D Prieto; María E Vela; José Luis Ríos; M Alejandra Tricerri; Omar J Rimoldi
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

7.  Amyloidogenic propensity of a natural variant of human apolipoprotein A-I: stability and interaction with ligands.

Authors:  Silvana A Rosú; Omar J Rimoldi; Eduardo D Prieto; Lucrecia M Curto; José M Delfino; Nahuel A Ramella; M Alejandra Tricerri
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

8.  Conformational Stability of the NH2-Terminal Propeptide of the Precursor of Pulmonary Surfactant Protein SP-B.

Authors:  Ángeles Bañares-Hidalgo; Jesús Pérez-Gil; Pilar Estrada
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.